Ferring plans to lay off 500 employees, or approximately 7% of its staff, as part of a streamlining effort, the company said in a brief statement. More: Ferring to reduce global head count by 500 as part of reorganization Source:
read moreEying a multiple sclerosis drug that it has tabbed with peak annual sales potential of $12 billion in the U.S. alone, Zenas BioPharma has struck a licensing deal with China-based InnoCare Pharma that could be worth more than $2 billion.
read moreWith a pair of new athletic partnerships under its belt, Vanda Pharmaceuticals is suiting up as a multisport player. More: Vanda signs on as NHL’s 1st pharma patch sponsor in Islanders deal, inks DC arena partnership Source: fierce
read moreThe U.K. government is in “advanced talks” with the U.S. and aims to fend off potential tariffs by raising its standard cost-effectiveness threshold for new medicines, according to Politico. More: UK floats plan to fend off Trump tariffs by raising
read more
Positive safety and pharmacokinetic data lay foundation for phase 2 study in 2026 More: Herantis advances HER-096 after successful Phase 1b Parkinson’s trial Source: News
read moreVifor Pharma is letting go of 55 employees who report to the Swiss company’s primary U.S. office in King of Prussia, Pennsylvania, just outside Philadelphia, according to a Worker Adjustment and Retraining Notification Act report filed with the state. The
read more© 1994 - 2025 B.M. Pharmaceuticals